NCT06599749View on ClinicalTrials.gov

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions

Adenocarcinoma of OvaryAdenocarcinoma, TubularPeritoneal Cancer

Trial Locations (3)

4031

University Hospital Basel, Basel

4410

Kantonsspital Baselland, Liestal

8091

University Hospital Zurich, Zurich

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER

NCT06599749 - Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn) | Biotech Hunter | Biotech Hunter